Latest News - 滙特生物科技股份有限公司

BioFirst announces: planning to build the first GMP medical device premise with production capacity of “Artificial Vitreous” for over 10 billion in Hsinchu Biomedical Science Park (August 12,2014)

2014-08-12
BioFirst obtains patent protection for “Ophthalmic Surgical Fluid” in Canada right after Australia (August 07,2014)

2014-08-07
Good news for BioFirst: Further advanced on global patent.

2014-07-29
Based on market research report, the global potential market of the “Artificial Vitreous” is estimated US$2 Billion annually. BioFirst received Global authorization right from the NHRI (National Health Research Institution), obtaining patent approvals fur

2014-07-28
BioFirst Corp (6458) registered in Emerging Stock Market (July 15, 2014)

2014-07-15
Announcement: OTC trading date for BioFirst Corp’s common stock in Gre-Tai Securities Market (July 10, 2014)

2014-07-10

Page 1 of 2

Start
Prev
1
2
Next
End

©2025 滙特生物科技股份有限公司 | Designed by Hurricane Med i a